Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
35 studies found for:    " March 06, 2013":" April 05, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Enrolling by invitation Transmission Reduction Intervention Project
Condition: HIV
Interventions: Other: Assays;   Other: HIV medical care;   Other: Social network and venue tracing;   Other: Community alerts;   Other: Community education;   Behavioral: HIV counseling
22 Terminated
Has Results
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Condition: Human Immunodeficiency Virus
Intervention:
23 Enrolling by invitation Social Network Intervention to Engage Out-of-Care PLH Into Treatment
Conditions: HIV;   AIDS
Interventions: Behavioral: Social Network Leader Endorsement;   Behavioral: HIV Counseling
24 Completed A Prospective, With One Site, Open-label Not Controled Trial, for the Observation of Treatment With CIDOFOVIR 1%, 3 Nights Per Week, During 4 Weeks, of Anal Intraepithelial Neoplasia, High Level, in HIV+ Patients
Condition: HIV
Intervention: Drug: Cidofovir 1% cream's basis, 2gr, three times per week, during 4 weeks.
25 Completed Treatment With Rosuvastatin Versus Switching PI (Protease Inhibitor) in Patients HIV With High Cholesterol Levels
Conditions: HIV;   Hypercholesterolaemia
Interventions: Drug: Switch ritonavir-boosted PI;   Drug: Continue Ritonavir-boosted PI+Rosuvastatin
26 Completed In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products
Condition: HIV Prevention
Interventions: Drug: Tenofovir 1% gel;   Drug: Vaginal product
27 Completed Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity
Condition: HIV Prevention
Interventions: Drug: TFV 1% gel;   Drug: Estradiol vaginal cream
28 Completed Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected Women
Conditions: Influenza;   Human Immunodeficiency Virus
Intervention: Biological: Trivalent Inactivated Influenza Vaccine
29 Completed THISTLE - The HIV-HCV Silibinin Trial
Conditions: HIV;   Hepatitis C
Intervention: Drug: Intravenous Silibinin (iSIL)
30 Completed Risky Decision Making in Methamphetamine Users: The Role of Opioid Blockade
Conditions: Methamphetamine Abuse;   HIV
Interventions: Drug: Extended release naltrexone;   Drug: Placebo
31 Active, not recruiting Enhancing Quality Interventions Promoting Healthy Sexuality
Conditions: Pregnancy in Adolescence;   HIV
Interventions: Behavioral: Making Proud Choices;   Behavioral: Making Proud Choices AND Getting To Outcomes
32 Withdrawn Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya
Conditions: Influenza, Human;   HIV;   Malaria;   Tetanus;   Polio
Interventions: Biological: Quadrivalent Inactivated Influenza Vaccine (QIV);   Biological: Inactivated Polio Vaccine;   Biological: Double Dose QIV
33 Completed UCLA-Amity Parolee Health Promotion Study
Conditions: Hepatitis B;   Hepatitis C;   HIV;   Drug Addiction
Interventions: Behavioral: Parolee Comprehensive Care + Phone Coach;   Behavioral: Parolee Brief HBV Program + Phone Coach;   Behavioral: Usual Care Group
34 Recruiting Cabozantinib-S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus
Conditions: Advanced Malignant Neoplasm;   HIV Infection;   Metastatic Malignant Neoplasm;   Recurrent Malignant Neoplasm;   Solid Neoplasm;   Unresectable Malignant Neoplasm
Interventions: Drug: Cabozantinib S-malate;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
35 Completed Clinical Monitoring to Facilitate Continuous Care for Substance Abusing Clients
Conditions: Substance-Related Disorders;   Mental Disorders
Intervention: Behavioral: RecoveryTrack - Extended Care (RT-E)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-35) Next Page   
Study has passed its completion date and status has not been verified in more than two years.